These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
4695 related items for PubMed ID: 30670911
1. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX, Zhang X, Miao RC, Xiang XH, Fu YN, Zhang JY, Liu C, Qu K. World J Gastroenterol; 2019 Jan 14; 25(2):220-232. PubMed ID: 30670911 [Abstract] [Full Text] [Related]
2. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma. Zhao QJ, Zhang J, Xu L, Liu FF. World J Gastroenterol; 2018 Aug 14; 24(30):3426-3439. PubMed ID: 30122881 [Abstract] [Full Text] [Related]
3. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma. Fu Y, Wei X, Han Q, Le J, Ma Y, Lin X, Xu Y, Liu N, Wang X, Kong X, Gu J, Tong Y, Wu H. BMC Cancer; 2021 Oct 30; 21(1):1165. PubMed ID: 34717566 [Abstract] [Full Text] [Related]
4. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma. Yan J, Zhou C, Guo K, Li Q, Wang Z. J Cell Biochem; 2019 Jan 30; 120(1):213-223. PubMed ID: 30206981 [Abstract] [Full Text] [Related]
5. 15-lncRNA-Based Classifier-Clinicopathologic Nomogram Improves the Prediction of Recurrence in Patients with Hepatocellular Carcinoma. Zhang Q, Ning G, Jiang H, Huang Y, Piao J, Chen Z, Tan X, Zhang J, Liu G. Dis Markers; 2020 Jan 30; 2020():9180732. PubMed ID: 33520012 [Abstract] [Full Text] [Related]
7. Identification and validation of a potent multi-mRNA signature for the prediction of early relapse in hepatocellular carcinoma. Cai J, Tong Y, Huang L, Xia L, Guo H, Wu H, Kong X, Xia Q. Carcinogenesis; 2019 Jul 20; 40(7):840-852. PubMed ID: 31059567 [Abstract] [Full Text] [Related]
8. A five lncRNA signature for prognosis prediction in hepatocellular carcinoma. Sun Y, Zhang F, Wang L, Song X, Jing J, Zhang F, Yu S, Liu H. Mol Med Rep; 2019 Jun 20; 19(6):5237-5250. PubMed ID: 31059056 [Abstract] [Full Text] [Related]
9. A Cuproptosis-Related LncRNA Risk Model for Predicting Prognosis and Immunotherapeutic Efficacy in Patients with Hepatocellular Carcinoma. Wang S, Bai H, Fei S, Miao B. Biochem Genet; 2024 Jun 20; 62(3):2332-2351. PubMed ID: 37898914 [Abstract] [Full Text] [Related]
13. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma. Li L, Xie R, Lu G. Biosci Rep; 2021 Jun 25; 41(6):. PubMed ID: 34027555 [Abstract] [Full Text] [Related]
14. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma. Mou Y, Wang D, Xing R, Nie H, Mou Y, Zhang Y, Zhou X. Cancer Biomark; 2018 Jun 25; 23(1):95-106. PubMed ID: 29991128 [Abstract] [Full Text] [Related]
17. A Five-Gene Signature for Recurrence Prediction of Hepatocellular Carcinoma Patients. Wang Z, Zhang N, Lv J, Ma C, Gu J, Du Y, Qiu Y, Zhang Z, Li M, Jiang Y, Zhao J, Du H, Zhang Z, Lu W, Zhang Y. Biomed Res Int; 2020 Jun 25; 2020():4037639. PubMed ID: 33163533 [Abstract] [Full Text] [Related]
18. Characterization of long non-coding RNAs to reveal potential prognostic biomarkers in hepatocellular carcinoma. Ma Y, Luo T, Dong D, Wu X, Wang Y. Gene; 2018 Jul 15; 663():148-156. PubMed ID: 29684484 [Abstract] [Full Text] [Related]
19. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis. Shi XM, Teng F. Int J Clin Exp Pathol; 2015 Jul 15; 8(4):4008-14. PubMed ID: 26097588 [Abstract] [Full Text] [Related]